DEVELOPMENT OF NOVEL COPOLYOXETANES: ANTIMICROBIAL AGENTS

This thesis focuses on solution antimicrobial effectiveness for copolyoxetanes with quaternary ammonium and PEG-like side chains. Ring opening copolymerization of 3-((4-bromobutoxy)methyl)-3-methyloxetane (BBOx) and 3-((2-(2-methoxyethoxy) ethoxy) methyl)-3-methyloxetane (ME2Ox) yielded random copol...

Full description

Bibliographic Details
Main Author: King, Allison
Format: Others
Published: VCU Scholars Compass 2011
Subjects:
MIC
HFF
HDF
Online Access:http://scholarscompass.vcu.edu/etd/293
http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=1292&context=etd
id ndltd-vcu.edu-oai-scholarscompass.vcu.edu-etd-1292
record_format oai_dc
spelling ndltd-vcu.edu-oai-scholarscompass.vcu.edu-etd-12922017-03-17T08:30:56Z DEVELOPMENT OF NOVEL COPOLYOXETANES: ANTIMICROBIAL AGENTS King, Allison This thesis focuses on solution antimicrobial effectiveness for copolyoxetanes with quaternary ammonium and PEG-like side chains. Ring opening copolymerization of 3-((4-bromobutoxy)methyl)-3-methyloxetane (BBOx) and 3-((2-(2-methoxyethoxy) ethoxy) methyl)-3-methyloxetane (ME2Ox) yielded random copolymers with 14-100 (m) mole% BBOx designated P[(BBOx-m)(ME2Ox)]. Reaction of P[(BBOx-m)(ME2Ox)] with dodecyl dimethylamine gave the corresponding quaternary P[(C12-m)(ME2Ox)] polycation salts, designated C12-m. Mole ratios and molecular weights were obtained from 1H-NMR and end group analysis. Differential scanning calorimetry (DSC) studies showed Tg’s between 69 and -34 °C. Minimum inhibitory concentrations (MIC) against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa showed MIC decreasing with increasing C12 mole% reaching a minimum between C12-43 and C12-60. C12-43 had the lowest MIC for all strains. At 5× MIC (challenge:108 cfu/ml), C12 43 kills ≥ 99% of the tested strains within 1 hr. C12-m copolyoxetane cytotoxicity toward human red blood cells, HFF (Human Foreskin Fibroblast) and HDF (Human Dermal Fibroblast) was low, indicating good prospects for biocompatibility. Cx-m copolyoxetane antimicrobial efficacy, hemolytic activity and cytotoxicity were further explored by changing quaternary alkyl chain length. Copolyoxetanes are represented as Cx-50, where 50 is the mole percent quaternary repeat units and ‘x’ is quaternary alkyl chain length (2 to 16 carbons). Reaction of P[(BBOx-m)(ME2Ox)] with a series of tertiary amines yielded the desired quaternary ammonium segment. DSC studies showed Tg’s between -40 °C and -60 °C and melting endotherms for C14-50 and C16-50. A systematic dependence of alkyl chain length on MIC was found with C8-50 being the most effective antimicrobial. Kill kinetics for C8-50 (5× MIC, challenge: 108 cfu/ml) effected >99% kill in 1 hour for S. aureus (7 log reduction). C8-50 efficacy on biomass and cell viability of P. aeruginosa biofilms was investigated. Crystal violet (CV) staining assays demonstrate that C8-50 had no effect on adhesion of already established P. aeruginosa biofilms, but reduced biofilm formation by killing cells prior to attachment. For anti-adhesion assays, noticeable reduction in biofilm mass occurred at concentrations greater than 2× MIC. Viability studies show a substantial log reduction of 2.1 at MIC. The low cytotoxicity of Cx-m copolyoxetanes coupled with low MICs and favorable biofilm results indicate good prospects for therapeutic applications. 2011-01-01T08:00:00Z text application/pdf http://scholarscompass.vcu.edu/etd/293 http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=1292&context=etd © The Author Theses and Dissertations VCU Scholars Compass copolyoxetane MIC HC50 EC50 antimicrobial polycation Pseudomonas aeruginosa biofilm HFF HDF Engineering
collection NDLTD
format Others
sources NDLTD
topic copolyoxetane
MIC
HC50
EC50
antimicrobial
polycation
Pseudomonas aeruginosa biofilm
HFF
HDF
Engineering
spellingShingle copolyoxetane
MIC
HC50
EC50
antimicrobial
polycation
Pseudomonas aeruginosa biofilm
HFF
HDF
Engineering
King, Allison
DEVELOPMENT OF NOVEL COPOLYOXETANES: ANTIMICROBIAL AGENTS
description This thesis focuses on solution antimicrobial effectiveness for copolyoxetanes with quaternary ammonium and PEG-like side chains. Ring opening copolymerization of 3-((4-bromobutoxy)methyl)-3-methyloxetane (BBOx) and 3-((2-(2-methoxyethoxy) ethoxy) methyl)-3-methyloxetane (ME2Ox) yielded random copolymers with 14-100 (m) mole% BBOx designated P[(BBOx-m)(ME2Ox)]. Reaction of P[(BBOx-m)(ME2Ox)] with dodecyl dimethylamine gave the corresponding quaternary P[(C12-m)(ME2Ox)] polycation salts, designated C12-m. Mole ratios and molecular weights were obtained from 1H-NMR and end group analysis. Differential scanning calorimetry (DSC) studies showed Tg’s between 69 and -34 °C. Minimum inhibitory concentrations (MIC) against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa showed MIC decreasing with increasing C12 mole% reaching a minimum between C12-43 and C12-60. C12-43 had the lowest MIC for all strains. At 5× MIC (challenge:108 cfu/ml), C12 43 kills ≥ 99% of the tested strains within 1 hr. C12-m copolyoxetane cytotoxicity toward human red blood cells, HFF (Human Foreskin Fibroblast) and HDF (Human Dermal Fibroblast) was low, indicating good prospects for biocompatibility. Cx-m copolyoxetane antimicrobial efficacy, hemolytic activity and cytotoxicity were further explored by changing quaternary alkyl chain length. Copolyoxetanes are represented as Cx-50, where 50 is the mole percent quaternary repeat units and ‘x’ is quaternary alkyl chain length (2 to 16 carbons). Reaction of P[(BBOx-m)(ME2Ox)] with a series of tertiary amines yielded the desired quaternary ammonium segment. DSC studies showed Tg’s between -40 °C and -60 °C and melting endotherms for C14-50 and C16-50. A systematic dependence of alkyl chain length on MIC was found with C8-50 being the most effective antimicrobial. Kill kinetics for C8-50 (5× MIC, challenge: 108 cfu/ml) effected >99% kill in 1 hour for S. aureus (7 log reduction). C8-50 efficacy on biomass and cell viability of P. aeruginosa biofilms was investigated. Crystal violet (CV) staining assays demonstrate that C8-50 had no effect on adhesion of already established P. aeruginosa biofilms, but reduced biofilm formation by killing cells prior to attachment. For anti-adhesion assays, noticeable reduction in biofilm mass occurred at concentrations greater than 2× MIC. Viability studies show a substantial log reduction of 2.1 at MIC. The low cytotoxicity of Cx-m copolyoxetanes coupled with low MICs and favorable biofilm results indicate good prospects for therapeutic applications.
author King, Allison
author_facet King, Allison
author_sort King, Allison
title DEVELOPMENT OF NOVEL COPOLYOXETANES: ANTIMICROBIAL AGENTS
title_short DEVELOPMENT OF NOVEL COPOLYOXETANES: ANTIMICROBIAL AGENTS
title_full DEVELOPMENT OF NOVEL COPOLYOXETANES: ANTIMICROBIAL AGENTS
title_fullStr DEVELOPMENT OF NOVEL COPOLYOXETANES: ANTIMICROBIAL AGENTS
title_full_unstemmed DEVELOPMENT OF NOVEL COPOLYOXETANES: ANTIMICROBIAL AGENTS
title_sort development of novel copolyoxetanes: antimicrobial agents
publisher VCU Scholars Compass
publishDate 2011
url http://scholarscompass.vcu.edu/etd/293
http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=1292&context=etd
work_keys_str_mv AT kingallison developmentofnovelcopolyoxetanesantimicrobialagents
_version_ 1718428665742622720